Skip to content
CNS Clinical Research

Aurora, Colorado

CNS clinical trials in Aurora, CO

54 CNS studies are recruiting participants at sites in Aurora as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Aurora at a glance

  • 54 studies are recruiting at a site in Aurora.
  • By phase: Phase 1/2 (3), Phase 2 (5), Phase 2/3 (1), Phase 3 (16), Phase 4 (4), No phase (14), Observational (11). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (27), industry (23), government (4).
  • By research area: Depression (14), Parkinson's Disease (14), Epilepsy (8), Migraine (8), Multiple Sclerosis (8), ADHD (1), Schizophrenia (1).
  • Most recent update to one of these records: November 13, 2026.

Depression studies recruiting in Aurora

Basic details from each study's public record (the 30 most recently updated of 54). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Study site
    University of Colorado
    Registry record
    NCT07002034 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    UCHealth University of Colorado Hospital
    Registry record
    NCT06748222 · updated
  3. TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

    • Observational
    • From 18 months, up to 11 years
    • All sexes
    Sponsor
    State University of New York at Buffalo
    Study site
    Children's Hospital Colorado
    Registry record
    NCT07048574 · updated
  4. Brexanolone Lifting Outcomes Of Moms

    • Phase 3
    • Ages 15 to 45
    • Female participants
    Sponsor
    Lipocine Inc.
    Study site
    Lipocine Investigational Site
    Registry record
    NCT07822321 · updated
  5. Modulating Exercise Dosage to Improve Concussion Recovery

    • Phase 1/2
    • Ages 13 to 18
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    University of Colorado Denver
    Registry record
    NCT05434130 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Aurora, CO on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Aurora

  1. Neocortical Microarchitecture of Executive Function

    • No phase
    • Ages 45 to 85
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    University of Colorado
    Registry record
    NCT06778135 · updated
  2. Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Boston Scientific Corporation
    Study site
    University of Colorado
    Registry record
    NCT02071134 · updated
  3. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of Colorado Anschutz Medical Campus ( Site 0151)
    Registry record
    NCT06623422 · updated
  4. An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Study site
    University of Colorado Anschutz
    Registry record
    NCT06996652 · updated
  5. A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

    • Phase 3
    • Ages 45 to 75
    • All sexes
    Sponsor
    BlueRock Therapeutics
    Study site
    University of Colorado Hospital - Neurology Clinic
    Registry record
    NCT06944522 · updated
  6. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    • Phase 2
    • Ages 40 to 80
    • All sexes
    Sponsor
    Neuron23 Inc.
    Study site
    University of Colorado - Anschutz Medical Campus
    Registry record
    NCT06680830 · updated
  7. Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    University of Colorado
    Registry record
    NCT07808346 · updated
  8. A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

    • Phase 2/3
    • Ages 40 to 80
    • All sexes
    Sponsor
    Biohaven Therapeutics Ltd.
    Registry record
    NCT06976268 · updated
  9. A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of Colorado Anschutz Medical Campus ( Site 0061)
    Registry record
    NCT06312176 · updated
  10. Parkinson's Foundation PD GENEration Genetic Registry

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Parkinson's Foundation
    Study site
    University of Colorado Anschutz
    Registry record
    NCT04994015 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Aurora, CO on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Aurora

  1. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Study site
    TG Therapeutics Investigational Trial Site
    Registry record
    NCT06433752 · updated
  2. Care in Multiple Sclerosis (MS)

    • Observational
    • Ages 18 to 29
    • All sexes
    Sponsor
    NYU Langone Health
    Study site
    University of Colorado Denver
    Registry record
    NCT07011914 · updated
  3. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    • Phase 3
    • Ages 18 to 55
    • All sexes
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Study site
    Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine
    Registry record
    NCT04047628 · updated
  4. A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    UC Health Neuroscience Ctr
    Registry record
    NCT07225504 · updated
  5. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Sanofi
    Study site
    Rocky Mountain Regional VA Medical Center- Site Number : 8400121
    Registry record
    NCT07325292 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Aurora, CO on ClinicalTrials.gov.

Epilepsy studies recruiting in Aurora

  1. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Study site
    University of Colorado Anschutz Medical Campus
    Registry record
    NCT05135091 · updated
  2. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    Colorado Children's Hospital
    Registry record
    NCT05419492 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Aurora, CO on ClinicalTrials.gov.

Migraine studies recruiting in Aurora

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    University of Colorado Anschutz Medical Campus
    Registry record
    NCT06972056 · updated
  2. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Paradigm Clinical Research Centers, LLC; Aurora
    Registry record
    NCT07816367 · updated
  3. Headache Education and Awareness vs. Daily Mindfulness Strategies - Understanding Pain

    • No phase
    • Ages 12 to 17
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    Children's Hospital Colorado
    Registry record
    NCT07513662 · updated
  4. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Children's Hospital Colorado · Children's Hospital Colorado- lnvestigational Drug Services
    Registry record
    NCT04649242 · updated
  5. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Children's Hospital Colorado · Children's Hospital Colorado- Investigational Drug Services
    Registry record
    NCT04743141 · updated
  6. Responding With Evidence and Access for Childhood Headaches

    • No phase
    • Ages 10 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    University of Colorado/Children's Hospital Colorado
    Registry record
    NCT05889624 · updated
  7. Puberty, Testosterone, and Brain Development

    • Observational
    • Ages 12 to 20
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    Children's Hospital Colorado
    Registry record
    NCT06670053 · updated
  8. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study sites
    Children's Hospital Colorado - Aurora /ID# 231879 · Paradigm Clinical Research - Aurora, CO /ID# 280612
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Aurora, CO on ClinicalTrials.gov.

Ask about studies near Aurora

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call